Skip to main content
NCBI home page
Microbiological Reviews logoLink to Microbiological Reviews
. 1981 Jun;45(2):244–266. doi: 10.1128/mr.45.2.244-266.1981

The interferon renaissance: molecular aspects of induction and action.

J Gordon, M A Minks
PMCID: PMC281508  PMID: 6167846

Full text

PDF
244

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adolf G. R., Swetly P. Interferon production by human lymphoblastoid cells is stimulated by inducers of Friend cell differentiation. Virology. 1979 Nov;99(1):158–166. doi: 10.1016/0042-6822(79)90047-3. [DOI] [PubMed] [Google Scholar]
  2. Aguet M. High-affinity binding of 125I-labelled mouse interferon to a specific cell surface receptor. Nature. 1980 Apr 3;284(5755):459–461. doi: 10.1038/284459a0. [DOI] [PubMed] [Google Scholar]
  3. Allen G., Fantes K. H. A family of structural genes for human lymphoblastoid (leukocyte-type) interferon. Nature. 1980 Oct 2;287(5781):408–411. doi: 10.1038/287408a0. [DOI] [PubMed] [Google Scholar]
  4. Arana R., Seligmann M. Antibodies to native and denatured deoxyribonucleic acid in systemic lupus erythematosus. J Clin Invest. 1967 Nov;46(11):1867–1882. doi: 10.1172/JCI105677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Aujean O., Sanceau J., Falcoff E., Falcoff R. Location of enhanced ribonuclease activity and of a phosphoprotein kinase in interferon-treated mengovirus-infected cells. Virology. 1979 Jan 30;92(2):583–586. doi: 10.1016/0042-6822(79)90162-4. [DOI] [PubMed] [Google Scholar]
  6. Baglioni C., Lenz J. R., Maroney P. A. The effect of salt concentration on the inhibition of protein synthesis by double-stranded RNA. Eur J Biochem. 1978 Dec 1;92(1):155–163. doi: 10.1111/j.1432-1033.1978.tb12733.x. [DOI] [PubMed] [Google Scholar]
  7. Baglioni C., Maroney P. A. Human leukocyte interferon induces 2', 5'-oligo (A) polymerase and protein kinase. Virology. 1980 Mar;101(2):540–544. doi: 10.1016/0042-6822(80)90470-5. [DOI] [PubMed] [Google Scholar]
  8. Baglioni C., Maroney P. A., West D. K. 2'5'Oligo(A) polymerase activity and inhibition of viral RNA synthesis in interferon-treated HeLa cells. Biochemistry. 1979 May 1;18(9):1765–1770. doi: 10.1021/bi00576a020. [DOI] [PubMed] [Google Scholar]
  9. Baglioni C., Minks M. A., Maroney P. A. Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A. Nature. 1978 Jun 22;273(5664):684–687. doi: 10.1038/273684a0. [DOI] [PubMed] [Google Scholar]
  10. Ball L. A. Induction of 2'5'-oligoadenylate synthetase activity and a new protein by chick interferon. Virology. 1979 Apr 30;94(2):282–296. doi: 10.1016/0042-6822(79)90462-8. [DOI] [PubMed] [Google Scholar]
  11. Ball L. A., White C. N. Effect of interferon pretreatment on coupled transcription and translation in cell-free extracts of primary chick embryo cells. Virology. 1978 Feb;84(2):496–508. doi: 10.1016/0042-6822(78)90265-9. [DOI] [PubMed] [Google Scholar]
  12. Ball L. A., White C. N. Nuclease activation by double-stranded RNA and by 2',5'-oligoadenylate in extracts of interferon-treated chick cells. Virology. 1979 Mar;93(2):348–356. doi: 10.1016/0042-6822(79)90239-3. [DOI] [PubMed] [Google Scholar]
  13. Ball L. A., White C. N. Oligonucleotide inhibitor of protein synthesis made in extracts of interferon-treated chick embryo cells: comparison with the mouse low molecular weight inhibitor. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1167–1171. doi: 10.1073/pnas.75.3.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Benne R., Salimans M., Goumans H., Amesz H., Voorma H. O. Regulation of protein synthesis in rabbit reticulocyte lysates. Phosphorylation of eIF-2 does not inhibit its capacity to recycle. Eur J Biochem. 1980 Mar;104(2):501–509. doi: 10.1111/j.1432-1033.1980.tb04452.x. [DOI] [PubMed] [Google Scholar]
  15. Benne R., Wong C., Luedi M., Hershey J. W. Purification and characterization of initiation factor IF-E2 from rabbit reticulocytes. J Biol Chem. 1976 Dec 10;251(23):7675–7681. [PubMed] [Google Scholar]
  16. Besançon F., Ankel H. Membrane receptors for interferon. Tex Rep Biol Med. 1977;35:282–292. [PubMed] [Google Scholar]
  17. Black D. R., Eckstein F., Hobbs J. B., Sternbach H., Merigan T. C. The antiviral activity of certain thiophosphate and 2'-chloro substituted polynucleotide homopolymer duplexes. Virology. 1972 May;48(2):537–545. doi: 10.1016/0042-6822(72)90064-5. [DOI] [PubMed] [Google Scholar]
  18. Blalock J. E., Baron S. Interferon-induced transfer of viral resistance between animal cells. Nature. 1977 Sep 29;269(5627):422–425. doi: 10.1038/269422a0. [DOI] [PubMed] [Google Scholar]
  19. Blalock J. E., Baron S. Mechanisms of interferon induced transfer of viral resistance between animal cells. J Gen Virol. 1979 Feb;42(2):363–372. doi: 10.1099/0022-1317-42-2-363. [DOI] [PubMed] [Google Scholar]
  20. Blalock J. E., Georgiades J. A., Langford M. P., Johnson H. M. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon. Cell Immunol. 1980 Feb;49(2):390–394. doi: 10.1016/0008-8749(80)90041-6. [DOI] [PubMed] [Google Scholar]
  21. Blalock J. E., Stanton G. J. Efficient transfer of interferon-induced virus resistance between human cells. J Gen Virol. 1978 Nov;41(2):325–331. doi: 10.1099/0022-1317-41-2-325. [DOI] [PubMed] [Google Scholar]
  22. Bodo G., Jungwirth C. Effect of interferon on deoxyribonuclease induction in chick fibroblast cultures infected with cowpox virus. J Virol. 1967 Jun;1(3):466–471. doi: 10.1128/jvi.1.3.466-471.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Bodo G., Scheirer W., Suh M., Schultze B., Horak I., Jungwirth C. Protein synthesis in pox-infected cells treated with interferon. Virology. 1972 Oct;50(1):140–147. doi: 10.1016/0042-6822(72)90354-6. [DOI] [PubMed] [Google Scholar]
  24. Borden E. C. Interferons: rationale for clinical trials in neoplastic disease. Ann Intern Med. 1979 Sep;91(3):472–479. doi: 10.7326/0003-4819-91-3-472. [DOI] [PubMed] [Google Scholar]
  25. Borecký L. Use of bacteriophage nucleic acid inducers of interferon in man. Tex Rep Biol Med. 1977;35:535–540. [PubMed] [Google Scholar]
  26. Bouloy M., Plotch S. J., Krug R. M. Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4886–4890. doi: 10.1073/pnas.75.10.4886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Brown G. E., Lebleu B., Kawakita M., Shaila S., Sen G. C., Lengyel P. Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: dependence of double-stranded RNA;. Biochem Biophys Res Commun. 1976 Mar 8;69(1):114–122. doi: 10.1016/s0006-291x(76)80280-x. [DOI] [PubMed] [Google Scholar]
  28. Cabrer B., Taira H., Broeze R. J., Kempe T. D., Williams K., Slattery E., Konigsberg W. H., Lengyel P. Structural characteristics of interferons from mouse Ehrlich ascites tumor cells. J Biol Chem. 1979 May 25;254(10):3681–3684. [PubMed] [Google Scholar]
  29. Carter W. A. Glycosylation, intraspecies molecular heterogeneity and trans-species activity of mammalian interferons. Life Sci. 1979 Aug 27;25(9):717–728. doi: 10.1016/0024-3205(79)90514-9. [DOI] [PubMed] [Google Scholar]
  30. Carter W. A., Pitha P. M., Marshall L. W., Tazawa I., Tazawa S., Ts'o P. O. Structural requirements of the rI n -rC n complex for induction of human interferon. J Mol Biol. 1972 Oct 14;70(3):567–587. doi: 10.1016/0022-2836(72)90560-8. [DOI] [PubMed] [Google Scholar]
  31. Champney K. J., Levine D. P., Levy H. B., Lerner A. M. Modified polyriboinosinic-polyribocytidylic acid complex: sustained interferonemia and its physiological associates in humans. Infect Immun. 1979 Sep;25(3):831–837. doi: 10.1128/iai.25.3.831-837.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Chernajovsky Y., Kimchi A., Schmidt A., Zilberstein A., Revel M. Differential effects of two interferon-induced translational inhibitors on initiation of protein synthesis. Eur J Biochem. 1979 May 2;96(1):35–41. doi: 10.1111/j.1432-1033.1979.tb13010.x. [DOI] [PubMed] [Google Scholar]
  33. Clemens M. J., Safer B., Merrick W. C., Anderson W. F., London I. M. Inhibition of protein synthesis in rabbit reticulocyte lysates by double-stranded RNA and oxidized glutathione: indirect mode of action on polypeptide chain initiation. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1286–1290. doi: 10.1073/pnas.72.4.1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Clemens M. J., Vaquero C. M. Inhibition of protein synthesis by double-stranded RNA in reticulocyte lysates: evidence for activation of an endoribonuclease. Biochem Biophys Res Commun. 1978 Jul 14;83(1):59–68. doi: 10.1016/0006-291x(78)90397-2. [DOI] [PubMed] [Google Scholar]
  35. Cohen S. A., Hughes G. R., Noel G. L., Christian C. L. Character of anti-DNA antibodies in systemic lupus erythematosus. Clin Exp Immunol. 1971 Apr;8(4):551–561. [PMC free article] [PubMed] [Google Scholar]
  36. Colby C., Chamberlin M. J. The specificity of interferon induction in chick embryo cells by helical RNA. Proc Natl Acad Sci U S A. 1969 May;63(1):160–167. doi: 10.1073/pnas.63.1.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Colby C., Duesberg P. H. Double-stranded RNA in vaccinia virus infected cells. Nature. 1969 Jun 7;222(5197):940–944. doi: 10.1038/222940a0. [DOI] [PubMed] [Google Scholar]
  38. Colby C., Jr The induction of interferon by natural and synthetic polynucleotides.hs. Prog Nucleic Acid Res Mol Biol. 1971;11:1–32. doi: 10.1016/s0079-6603(08)60324-4. [DOI] [PubMed] [Google Scholar]
  39. Content J., Lebleu B., De Clercq E. Differential effects of various double-stranded RNAs on protein synthesis in rabbit reticulocyte lysates. Biochemistry. 1978 Jan 10;17(1):88–94. doi: 10.1021/bi00594a012. [DOI] [PubMed] [Google Scholar]
  40. Content J., Lebleu B., Nudel U., Zilberstein A., Berissi H., Revel M. Blocks in elongation and initiation of protein synthesis induced by interferon treatment in mouse L cells. Eur J Biochem. 1975 May;54(1):1–10. doi: 10.1111/j.1432-1033.1975.tb04106.x. [DOI] [PubMed] [Google Scholar]
  41. Content J., Lebleu B., Zilberstein A., Berissi H., Revel M. Mechanism of the interferon-induced block of mRNA translation in mouse L cells: reversal of the block by transfer RNA. FEBS Lett. 1974 Apr 15;41(1):125–130. doi: 10.1016/0014-5793(74)80970-1. [DOI] [PubMed] [Google Scholar]
  42. Cooper J. A., Farrell P. J. Extracts of interferon-treated cells can inhibit reticulocyte lysate protein synthesis. Biochem Biophys Res Commun. 1977 Jul 11;77(1):124–131. doi: 10.1016/s0006-291x(77)80173-3. [DOI] [PubMed] [Google Scholar]
  43. Cooper J. A., Morser J., Colby M. S., Burke D. C. The toxic effect of double-stranded RNA for interferon-treated cells: evidence for a heterogeneous cellular response and the role of the cell nucleus. J Gen Virol. 1979 Jun;43(3):553–561. doi: 10.1099/0022-1317-43-3-553. [DOI] [PubMed] [Google Scholar]
  44. Cooper J. A., Morser J. The toxic effect of double-stranded RNA for interferon-treated L cells: studies on membrane transport and with cell-free systems. J Gen Virol. 1979 Jun;43(3):563–569. doi: 10.1099/0022-1317-43-3-563. [DOI] [PubMed] [Google Scholar]
  45. Cornell C. J., Jr, Smith K. A., Cornwell G. G., 3rd, Burke G. P., McIntyre O. R. Ssytemic effects of intravenous polyriboinosinic-polyribocytidylic acid in man. J Natl Cancer Inst. 1976 Dec;57(6):1211–1216. doi: 10.1093/jnci/57.6.1211. [DOI] [PubMed] [Google Scholar]
  46. De Clercq E., Huang G. F., Bhooshan B., Ledley G., Torrence P. F. Interferon induction by mismatched analogues of polyinosinic acid . polycytidylic acid [(Ix,U)n.(C)n]. Nucleic Acids Res. 1979 Dec 11;7(7):2003–2014. doi: 10.1093/nar/7.7.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. De Clercq E., Stewart W. E., 2nd, De Somer P. Poly(rI) more important than poly(rC) in the interferon induction process by poly(rI)-poly(rC). Virology. 1973 Jul;54(1):278–282. doi: 10.1016/0042-6822(73)90137-2. [DOI] [PubMed] [Google Scholar]
  48. De Clercq E. Synthetic interferon inducers. Top Curr Chem. 1974;52:173–208. doi: 10.1007/3-540-06873-2_17. [DOI] [PubMed] [Google Scholar]
  49. De Maeyer-Guignard J., Tovey M. G., Gresser I., De Maeyer E. Purification of mouse interferon by sequential affinity chromatography on poly(U)--and antibody--agarose columns. Nature. 1978 Feb 16;271(5646):622–625. doi: 10.1038/271622a0. [DOI] [PubMed] [Google Scholar]
  50. De Maeyer E., De Maeyer Guignard J., Montagnier I. Double stranded RNA from rat liver induces interferon in rat cells. Nat New Biol. 1971 Jan 27;229(4):109–110. doi: 10.1038/newbio229109a0. [DOI] [PubMed] [Google Scholar]
  51. Derynck R., Content J., DeClercq E., Volckaert G., Tavernier J., Devos R., Fiers W. Isolation and structure of a human fibroblast interferon gene. Nature. 1980 Jun 19;285(5766):542–547. doi: 10.1038/285542a0. [DOI] [PubMed] [Google Scholar]
  52. Desrosiers R. C., Lengyel P. Impairment of reovirus mRNA 'cap' methylation in interferon-treated mouse L929 cells. Biochim Biophys Acta. 1979 May 24;562(3):471–480. doi: 10.1016/0005-2787(79)90110-2. [DOI] [PubMed] [Google Scholar]
  53. Ehrenfeld E., Hunt T. Double-stranded poliovirus RNA inhibits initiation of protein synthesis by reticulocyte lysates. Proc Natl Acad Sci U S A. 1971 May;68(5):1075–1078. doi: 10.1073/pnas.68.5.1075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Emeny J. M., Morgan M. J. Susceptibility of various cells treated with interferon to the toxic effect of poly(rI).poly(rC) treatment. J Gen Virol. 1979 Apr;43(1):253–255. doi: 10.1099/0022-1317-43-1-253. [DOI] [PubMed] [Google Scholar]
  55. Eppstein D. A., Peterson T. C., Samuel C. E. Mechanism of interferon action: synthesis and activity of the interferon-mediated low-molecular-weight oligonucleotide from murine and human cells. Virology. 1979 Oct 15;98(1):9–19. doi: 10.1016/0042-6822(79)90520-8. [DOI] [PubMed] [Google Scholar]
  56. Eppstein D. A., Samuel C. E. Mechanism of interferon action. Partial purification and characterization of a low-molecular-weight interferon-mediated inhibitor of translation with nucleolytic activity. Biochem Biophys Res Commun. 1977 Nov 7;79(1):145–153. doi: 10.1016/0006-291x(77)90072-9. [DOI] [PubMed] [Google Scholar]
  57. Eppstein D. A., Samuel C. E. Mechanism of interferon action. Properties of an interferon-mediated ribonucleolytic activity from mouse L929 cells. Virology. 1978 Aug;89(1):240–251. doi: 10.1016/0042-6822(78)90056-9. [DOI] [PubMed] [Google Scholar]
  58. Falcoff E., Falcoff R., Lebleu B., Revel M. Interferon treatment inhibits Mengo RNA and haemoglobin mRNA translation in cell-free extracts of L cells. Nat New Biol. 1972 Nov 29;240(100):145–147. doi: 10.1038/newbio240145a0. [DOI] [PubMed] [Google Scholar]
  59. Falcoff R., Falcoff E., Sanceau J., Lewis J. A. Influence of preincubation on the development of the inhibition of protein synthesis in extracts from interferon-treated mouse L cells. Action on tRNA. Virology. 1978 May 15;86(2):507–515. doi: 10.1016/0042-6822(78)90089-2. [DOI] [PubMed] [Google Scholar]
  60. Falcoff R., Lebleu B., Sanceau J., Weissenbach J., Dirheimer G., Ebel J. P., Falcoff E. The inhibition of translation of synthetic polyribonucleotides and mengo RNA in extracts from interferon-treated L cells and its reversion by yeast tRNAs. Biochem Biophys Res Commun. 1976 Feb 23;68(4):1323–1331. doi: 10.1016/0006-291x(76)90341-7. [DOI] [PubMed] [Google Scholar]
  61. Falcoff R., Sanceau J. Mengovirus-induced inhibition of cell protein synthesis and subsequent recovery of cellular activity in interferon-pretreated cells. Virology. 1979 Oct 30;98(2):433–438. doi: 10.1016/0042-6822(79)90565-8. [DOI] [PubMed] [Google Scholar]
  62. Farrell P. J., Balkow K., Hunt T., Jackson R. J., Trachsel H. Phosphorylation of initiation factor elF-2 and the control of reticulocyte protein synthesis. Cell. 1977 May;11(1):187–200. doi: 10.1016/0092-8674(77)90330-0. [DOI] [PubMed] [Google Scholar]
  63. Farrell P. J., Sen G. C., Dubois M. F., Ratner L., Slattery E., Lengyel P. Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci U S A. 1978 Dec;75(12):5893–5897. doi: 10.1073/pnas.75.12.5893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Field A. K., Lampson G. P., Tytell A. A., Nemes M. M., Hilleman M. R. Inducers of interferon and host resistance, IV. Double-stranded replicative form RNA (MS2-Ff-RNA) from E. coli infected with MS2 coliphage. Proc Natl Acad Sci U S A. 1967 Nov;58(5):2102–2108. doi: 10.1073/pnas.58.5.2102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Field A. K., Tytell A. A., Lampson G. P., Hilleman M. R. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes. Proc Natl Acad Sci U S A. 1967 Sep;58(3):1004–1010. doi: 10.1073/pnas.58.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Freeman A. I., Al-Bussam N., O'Malley J. A., Stutzman L., Bjornsson S., Carter W. A. Pharmacologic effects of polyinosinic-polycytidylic acid in man. J Med Virol. 1977;1(2):79–93. doi: 10.1002/jmv.1890010202. [DOI] [PubMed] [Google Scholar]
  67. Frey T. K., Jones E. V., Cardamone J. J., Jr, Youngner J. S. Induction of interferon in L cells by defective-interfering (DI) particles of vesicular stomatitis virus: lack of correlation with content of [+/-] snapback RNA. Virology. 1979 Nov;99(1):95–102. doi: 10.1016/0042-6822(79)90040-0. [DOI] [PubMed] [Google Scholar]
  68. Fujita T., Saito S., Kohno S. Priming increases the amount of interferon mRNA in poly(rI).poly(rC)-treated L cells. J Gen Virol. 1979 Nov;45(2):301–308. doi: 10.1099/0022-1317-45-2-301. [DOI] [PubMed] [Google Scholar]
  69. Fuller F. J., Marcus P. I. Interferon induction by viruses. IV. Sindbis virus: early passage defective-interfering particles induce interferon. J Gen Virol. 1980 May;48(1):63–73. doi: 10.1099/0022-1317-48-1-63. [DOI] [PubMed] [Google Scholar]
  70. Fuller F. J., Marcus P. I. Interferon induction by viruses. Sindbis virus: defective-interfering particles temperature-sensitive for interferon induction. J Gen Virol. 1980 Jun;48(Pt 2):391–394. doi: 10.1099/0022-1317-48-2-391. [DOI] [PubMed] [Google Scholar]
  71. Gerber M. A., Shapiro J. M., Smith H., Jr, Lebwohl O., Schaffner F. Antibodies to ribosomes in chronic active hepatitis. Gastroenterology. 1979 Jan;76(1):139–143. [PubMed] [Google Scholar]
  72. Ghosh S. N., Gifford G. E. Effect of interferon on the dynamics of H3-thymidine incorporation and thymidine kinase induction in chick fibroblast cultures infected with vaccinia virus. Virology. 1965 Oct;27(2):186–192. doi: 10.1016/0042-6822(65)90158-3. [DOI] [PubMed] [Google Scholar]
  73. Goeddel D. V., Kleid D. G., Bolivar F., Heyneker H. L., Yansura D. G., Crea R., Hirose T., Kraszewski A., Itakura K., Riggs A. D. Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci U S A. 1979 Jan;76(1):106–110. doi: 10.1073/pnas.76.1.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Goeddel D. V., Yelverton E., Ullrich A., Heyneker H. L., Miozzari G., Holmes W., Seeburg P. H., Dull T., May L., Stebbing N. Human leukocyte interferon produced by E. coli is biologically active. Nature. 1980 Oct 2;287(5781):411–416. doi: 10.1038/287411a0. [DOI] [PubMed] [Google Scholar]
  75. Greene J. J., Alderfer J. L., Tazawa I., Tazawa S., Ts'o P. O., O'Malley J. A., Carter W. A. Interferon induction and its dependence on the primary and secondary structure of poly(inosinic acid).poly(cytidylic acid). Biochemistry. 1978 Oct 3;17(20):4214–4220. doi: 10.1021/bi00613a016. [DOI] [PubMed] [Google Scholar]
  76. Gresser I., Tovey M. G. Antitumor effects of interferon. Biochim Biophys Acta. 1978 Oct 27;516(2):231–247. doi: 10.1016/0304-419x(78)90009-4. [DOI] [PubMed] [Google Scholar]
  77. Guggenheim M. A., Baron S. Clinical studies of an interferon inducer, polyriboinosinic-polyribocytidylic acid [poly (I)-poly (C)], in children. J Infect Dis. 1977 Jul;136(1):50–58. doi: 10.1093/infdis/136.1.50. [DOI] [PubMed] [Google Scholar]
  78. Gupta S. L., Sopori M. L., Lengyel P. Release of the inhibition of messenger RNA translation in extracts of interferon-treated Ehrlich ascites tumor cells by added transfer RNA. Biochem Biophys Res Commun. 1974 Apr 8;57(3):763–770. doi: 10.1016/0006-291x(74)90612-3. [DOI] [PubMed] [Google Scholar]
  79. Gupta S. L. Specific protein phosphorylation in interferon-treated uninfected and virus-infected mouse L929 cells: enhancement by double-stranded RNA. J Virol. 1979 Jan;29(1):301–311. doi: 10.1128/jvi.29.1.301-311.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Hayaishi O., Ueda K. Poly(ADP-ribose) and ADP-ribosylation of proteins. Annu Rev Biochem. 1977;46:95–116. doi: 10.1146/annurev.bi.46.070177.000523. [DOI] [PubMed] [Google Scholar]
  81. Ho M., Armstrong J. A. Interferon. Annu Rev Microbiol. 1975;29:131–161. doi: 10.1146/annurev.mi.29.100175.001023. [DOI] [PubMed] [Google Scholar]
  82. Hochkeppel H. K., Gordon J. Evidence for cross-linking of polyribonucleotides with 4'-aminomethyl-4,5',8-trimethylpsoralen hydrochloride. Biochemistry. 1979 Jun 26;18(13):2905–2910. doi: 10.1021/bi00580a035. [DOI] [PubMed] [Google Scholar]
  83. Hochkeppel H., Gordon J. Preparation-sensitive conformations in ribosomal RNAs. Nature. 1978 Jun 15;273(5663):560–562. doi: 10.1038/273560a0. [DOI] [PubMed] [Google Scholar]
  84. Houghton M., Stewart A. G., Doel S. M., Emtage J. S., Eaton M. A., Smith J. C., Patel T. P., Lewis H. M., Porter A. G., Birch J. R. The amino-terminal sequence of human fibroblast interferon as deduced from reverse transcripts obtained using synthetic oligonucleotide primers. Nucleic Acids Res. 1980 May 10;8(9):1913–1931. doi: 10.1093/nar/8.9.1913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Hovanessian A. G., Brown R. E., Kerr I. M. Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature. 1977 Aug 11;268(5620):537–540. doi: 10.1038/268537a0. [DOI] [PubMed] [Google Scholar]
  86. Hovanessian A. G., Kerr I. M. Synthesis of an oligonucleotide inhibitor of protein synthesis in rabbit reticulocyte lysates analogous to that formed in extracts from interferon-treated cells. Eur J Biochem. 1978 Mar;84(1):149–159. doi: 10.1111/j.1432-1033.1978.tb12151.x. [DOI] [PubMed] [Google Scholar]
  87. Hovanessian A. G., Kerr I. M. The (2'-5') oligoadenylate (pppA2'-5'A2'-5'A) synthetase and protein kinase(s) from interferon-treated cells. Eur J Biochem. 1979 Feb 1;93(3):515–526. doi: 10.1111/j.1432-1033.1979.tb12850.x. [DOI] [PubMed] [Google Scholar]
  88. Hovanessian A. G., Meurs E., Aujean O., Vaquero C., Stefanos S., Falcoff E. Antiviral response and induction of specific proteins in cells treated with immune T (type II) interferon analogous to that from viral interferon (type I)-treated cells. Virology. 1980 Jul 15;104(1):195–204. doi: 10.1016/0042-6822(80)90377-3. [DOI] [PubMed] [Google Scholar]
  89. Hovanessian A. G., Meurs E., Montagnier L. Lack of systematic correlation between the interferon mediated antiviral state and the levels of 2-5A synthetase and protein kinase in three different types of murine cells. J Interferon Res. 1981 Feb;1(2):179–190. doi: 10.1089/jir.1981.1.179. [DOI] [PubMed] [Google Scholar]
  90. Hovanessian A. G., Wood J. N. Anticellular and antiviral effects of pppA(2'p5'A)n. Virology. 1980 Feb;101(1):81–90. doi: 10.1016/0042-6822(80)90485-7. [DOI] [PubMed] [Google Scholar]
  91. Hovanessian A. G., Wood J., Meurs E., Montagnier L. Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3261–3265. doi: 10.1073/pnas.76.7.3261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Hunt T., Ehrenfeld E. Cytoplasm from poliovirus-infected HeLa cells inhibits cell-free haemoglobin synthesis. Nat New Biol. 1971 Mar 17;230(11):91–94. doi: 10.1038/newbio230091a0. [DOI] [PubMed] [Google Scholar]
  93. Hunter T., Hunt T., Jackson R. J., Robertson H. D. The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. J Biol Chem. 1975 Jan 25;250(2):409–417. [PubMed] [Google Scholar]
  94. Justesen J., Ferbus D., Thang M. N. 2'5' oligoadenylate synthetase, an interferon induced enzyme: direct assay methods for the products, 2'5' oligoadenylates and 2'5' co-oligonucleotides. Nucleic Acids Res. 1980 Jul 25;8(14):3073–3085. doi: 10.1093/nar/8.14.3073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Kaempfer R., Israeli R., Rosen H., Knoller S., Zilberstein A., Schmidt A., Revel M. Reversal of the interferon-induced block of protein synthesis by purified preparations of eucaryotic initiation factor 2. Virology. 1979 Nov;99(1):170–173. doi: 10.1016/0042-6822(79)90049-7. [DOI] [PubMed] [Google Scholar]
  96. Kerr I. M., Brown R. E., Ball L. A. Increased sensitivity of cell-free protein synthesis to double-stranded RNA after interferon treatment. Nature. 1974 Jul 5;250(461):57–59. doi: 10.1038/250057a0. [DOI] [PubMed] [Google Scholar]
  97. Kerr I. M., Brown R. E., Hovanessian A. G. Nature of inhibitor of cell-free protein synthesis formed in response to interferon and double-stranded RNA. Nature. 1977 Aug 11;268(5620):540–542. doi: 10.1038/268540a0. [DOI] [PubMed] [Google Scholar]
  98. Kerr I. M., Brown R. E. pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc Natl Acad Sci U S A. 1978 Jan;75(1):256–260. doi: 10.1073/pnas.75.1.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Kerr I. M., Friedman R. M., Brown R. E., Ball L. A., Brown J. C. Inhibition of Protein Synthesis in Cell-Free Systems from Interferon-Treated, Infected Cells: Further Characterization and Effect of Formylmethionyl-tRNA(F). J Virol. 1974 Jan;13(1):9–21. doi: 10.1128/jvi.13.1.9-21.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Kimball P. C., Duesberg P. H. Virus interference by cellular double-stranded ribonucleic acid. J Virol. 1971 Jun;7(6):697–706. doi: 10.1128/jvi.7.6.697-706.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Kimchi A., Shulman L., Schmidt A., Chernajovsky Y., Fradin A., Revel M. Kinetics of the induction of three translation-regulatory enzymes by interferon. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3208–3212. doi: 10.1073/pnas.76.7.3208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Kimchi A., Shure H., Revel M. Regulation of lymphocyte mitogenesis by (2'--5') oligo-isoadenylate. Nature. 1979 Dec 20;282(5741):849–851. doi: 10.1038/282849a0. [DOI] [PubMed] [Google Scholar]
  103. Kimchi A., Zilberstein A., Schmidt A., Shulman L., Revel M. The interferon-induced protein kinase PK-i from mouse L cells. J Biol Chem. 1979 Oct 10;254(19):9846–9853. [PubMed] [Google Scholar]
  104. Kleinschmidt W. J., Boeck L. D., Van Frank R. M., Murphy E. B., Hull R. N. Interferon production by phi6 Pseudomonas phaseolicola phage and its double-stranded RNA. Proc Soc Exp Biol Med. 1973 Oct 1;144(1):304–307. doi: 10.3181/00379727-144-37578. [DOI] [PubMed] [Google Scholar]
  105. Kleischmidt W. J., Ellis L. F., Van Frank R. M., Murphy E. B. Interferon stimulation by a double stranded RNA of a mycophage in statolon preparations. Nature. 1968 Oct 12;220(5163):167–168. doi: 10.1038/220167a0. [DOI] [PubMed] [Google Scholar]
  106. Knight E., Jr, Hunkapiller M. W., Korant B. D., Hardy R. W., Hood L. E. Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science. 1980 Feb 1;207(4430):525–526. doi: 10.1126/science.7352259. [DOI] [PubMed] [Google Scholar]
  107. Knight E., Jr Interferon: purification and initial characterization from human diploid cells. Proc Natl Acad Sci U S A. 1976 Feb;73(2):520–523. doi: 10.1073/pnas.73.2.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Knight M., Cayley P. J., Silverman R. H., Wreschner D. H., Gilbert C. S., Brown R. E., Kerr I. M. Radioimmune, radiobinding and HPLC analysis of 2-5A and related oligonucleotides from intact cells. Nature. 1980 Nov 13;288(5787):189–192. doi: 10.1038/288189a0. [DOI] [PubMed] [Google Scholar]
  109. Koffler D., Carr R., Agnello V., Thoburn R., Kunkel H. G. Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med. 1971 Jul 1;134(1):294–312. doi: 10.1084/jem.134.1.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Koffler D. Systemic lupus erythematosus. Sci Am. 1980 Jul;243(1):40–49. [PubMed] [Google Scholar]
  111. Krim M. Towards tumor therapy with interferons, part II. Interferons: in vivo effects. Blood. 1980 Jun;55(6):875–884. [PubMed] [Google Scholar]
  112. Krishnan I., Baglioni C. 2'5' oligo(A) polymerase activity in serum of mice infected with EMC virus or treated with interferon. Nature. 1980 Jun 12;285(5765):485–488. doi: 10.1038/285485a0. [DOI] [PubMed] [Google Scholar]
  113. Kroath H., Gross H. J., Jungwirth C., Bodo G. RNA methylation in vaccinia virus-infected chick embryo fibroblasts treated with homologous interferon. Nucleic Acids Res. 1978 Jul;5(7):2441–2454. doi: 10.1093/nar/5.7.2441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Kroath H., Janda H. G., Hiller G., Kuhn E., Jungwirth C., Gross H. J., Bodo G. Methylation of vaccinia virus-specific mRNA in the interferon-treated chick cell. Virology. 1979 Jan 30;92(2):572–577. doi: 10.1016/0042-6822(79)90160-0. [DOI] [PubMed] [Google Scholar]
  115. Lebleu B., Hubert E., Content J., De Wit L., Braude I. A., De Clercq E. Translation of mouse interferon mRNA in Xenopus laevis oocytes and in rabbit reticulocyte lysates. Biochem Biophys Res Commun. 1978 May 30;82(2):665–673. doi: 10.1016/0006-291x(78)90926-9. [DOI] [PubMed] [Google Scholar]
  116. Lebleu B., Sen G. C., Shaila S., Cabrer B., Lengyel P. Interferon, double-stranded RNA, and protein phosphorylation. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3107–3111. doi: 10.1073/pnas.73.9.3107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Legon S., Brayley A., Hunt T., Jackson R. J. The effect of cyclic AMP and related compounds on the control of protein synthesis in reticulocyte lysates. Biochem Biophys Res Commun. 1974 Feb 4;56(3):745–752. doi: 10.1016/0006-291x(74)90668-8. [DOI] [PubMed] [Google Scholar]
  118. Lerner M. R., Steitz J. A. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5495–5499. doi: 10.1073/pnas.76.11.5495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Levin D. H., Petryshyn R., London I. M. Characterization of double-stranded-RNA-activated kinase that phosphorylates alpha subunit of eukaryotic initiation factor 2 (eIF-2 alpha) in reticulocyte lysates. Proc Natl Acad Sci U S A. 1980 Feb;77(2):832–836. doi: 10.1073/pnas.77.2.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Levin D., London I. M. Regulation of protein synthesis: activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2. Proc Natl Acad Sci U S A. 1978 Mar;75(3):1121–1125. doi: 10.1073/pnas.75.3.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Levine A. S., Levy H. B. Phase I-II trials of poly IC stabilized with poly-L-lysine. Cancer Treat Rep. 1978 Nov;62(11):1907–1912. [PubMed] [Google Scholar]
  122. Levine A. S., Sivulich M., Wiernik P. H., Levy H. B. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer. Cancer Res. 1979 May;39(5):1645–1650. [PubMed] [Google Scholar]
  123. Levine S., Magee W. E., Hamilton R. D., Miller O. V. Effect of interferon on early enzyme and viral DNA synthesis in vaccinia virus infections. Virology. 1967 May;32(1):33–40. doi: 10.1016/0042-6822(67)90249-8. [DOI] [PubMed] [Google Scholar]
  124. Levy H. B., Baer G., Baron S., Buckler C. E., Gibbs C. J., Iadarola M. J., London W. T., Rice J. A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis. 1975 Oct;132(4):434–439. doi: 10.1093/infdis/132.4.434. [DOI] [PubMed] [Google Scholar]
  125. Levy H. B., Carter W. A. Molecular basis of the action of interferon. J Mol Biol. 1968 Feb 14;31(3):561–577. doi: 10.1016/0022-2836(68)90428-2. [DOI] [PubMed] [Google Scholar]
  126. Levy H. B., Lvovsky E. Topical treatment of vaccinia virus infection with an interferon inducer in rabbits. J Infect Dis. 1978 Jan;137(1):78–81. doi: 10.1093/infdis/137.1.78. [DOI] [PubMed] [Google Scholar]
  127. Lewis J. A., Falcoff E., Falcoff R. Dual action of double-stranded RNA inhibiting protein synthesis in extracts of interferon-treated mouse L cells. Translation is impaired at the level of initiation and by mRNA degradation. Eur J Biochem. 1978 May 16;86(2):497–509. doi: 10.1111/j.1432-1033.1978.tb12333.x. [DOI] [PubMed] [Google Scholar]
  128. Magee W. E. Potentiation of interferon production and stimulation of lymphocytes by polyribonucleotides entrapped in liposomes. Ann N Y Acad Sci. 1978;308:308–324. doi: 10.1111/j.1749-6632.1978.tb22032.x. [DOI] [PubMed] [Google Scholar]
  129. Mantei N., Schwarzstein M., Streuli M., Panem S., Nagata S., Weissmann C. The nucleotide sequence of a cloned human leukocyte interferon cDNA. Gene. 1980 Jun;10(1):1–10. doi: 10.1016/0378-1119(80)90137-7. [DOI] [PubMed] [Google Scholar]
  130. Marcus P. I., Sekellick M. J. Defective interfering particles with covalently linked [+/-]RNA induce interferon. Nature. 1977 Apr 28;266(5605):815–819. doi: 10.1038/266815a0. [DOI] [PubMed] [Google Scholar]
  131. Marcus P. I., Sekellick M. J. Interferon induction by viruses. III. Vesicular stomatitis virus: interferon-inducing particle activity requires partial transcription of gene N. J Gen Virol. 1980 Mar;47(1):89–96. doi: 10.1099/0022-1317-47-1-89. [DOI] [PubMed] [Google Scholar]
  132. Marcus P. I., Terry T. M., Levine S. Interferon action II. Membrane-bound alkaline ribonuclease activity in chick embryo cells manifesting interferon-mediated interference. Proc Natl Acad Sci U S A. 1975 Jan;72(1):182–186. doi: 10.1073/pnas.72.1.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Martin E. M., Birdsall N. J., Brown R. E., Kerr I. M. Enzymic synthesis, characterisation and nuclear-magnetic-resonance spectra of pppA2'p5'A2'p5'A and related oligonucleotides: comparison with chemically synthesised material. Eur J Biochem. 1979 Apr 2;95(2):295–307. doi: 10.1111/j.1432-1033.1979.tb12965.x. [DOI] [PubMed] [Google Scholar]
  134. Mayhew E., Papahadjopoulos D., O'Malley J. A., Carter W. A., Vail W. J. Cellular uptake and protection against virus infection by polyinosinic-polycytidylic acid entrapped within phospholipid vesicles. Mol Pharmacol. 1977 May;13(3):488–495. [PubMed] [Google Scholar]
  135. Mayr U., Bermayer H. P., Weidinger G., Jungwirth C. Release of interferon-induced translation inhibition by tRNA in cell-free extracts from mouse erythroleukemia cells. Eur J Biochem. 1977 Jun 15;76(2):541–551. doi: 10.1111/j.1432-1033.1977.tb11624.x. [DOI] [PubMed] [Google Scholar]
  136. Merigan T. C., Rottman F. Influence of increasing 2'-O-methylation on the interferon stimulating capacity of poly(rl)-poly(rC). Virology. 1974 Jul;60(1):297–301. doi: 10.1016/0042-6822(74)90389-4. [DOI] [PubMed] [Google Scholar]
  137. Metz D. H. Interferon and interferon inducers. Adv Drug Res. 1975;10:101–156. [PubMed] [Google Scholar]
  138. Meyer D. H., Meyer W. L. Increased enzymatic activity of the neutral ribonuclease II-inhibitor system of liver and muscle after the administration of polyinosinylyl-polycytidylyl complex to mice. Life Sci. 1979 Jan 1;24(1):51–58. doi: 10.1016/0024-3205(79)90279-0. [DOI] [PubMed] [Google Scholar]
  139. Minks M. A., Benvin S., Baglioni C. Mechanism of pppA(2'p5'A)n2'p5'AOH synthesis in extracts of interferon-treated HeLa cells. J Biol Chem. 1980 Jun 10;255(11):5031–5035. [PubMed] [Google Scholar]
  140. Minks M. A., Benvin S., Maroney P. A., Baglioni C. Metabolic stability of 2' 5'oligo (A) and activity of 2' 5'oligo (A)-dependent endonuclease in extracts of interferon-treated and control HeLa cells. Nucleic Acids Res. 1979 Feb;6(2):767–780. doi: 10.1093/nar/6.2.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Minks M. A., Benvin S., Maroney P. A., Baglioni C. Synthesis of 2'5'-oligo(A) in extracts of interferon-treated HeLa cells. J Biol Chem. 1979 Jun 25;254(12):5058–5064. [PubMed] [Google Scholar]
  142. Minks M. A., West D. K., Benvin S., Baglioni C. Structural requirements of double-stranded RNA for the activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J Biol Chem. 1979 Oct 25;254(20):10180–10183. [PubMed] [Google Scholar]
  143. Minks M. A., West D. K., Benvin S., Greene J. J., Ts'o P. O., Baglioni C. Activation of 2',5'-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells by 2'-O-methylated poly (inosinic acid) . poly(cytidylic acid), Correlations with interferon-inducing activity. J Biol Chem. 1980 Jul 10;255(13):6403–6407. [PubMed] [Google Scholar]
  144. Mogensen K. E., Pyhälä L., Törmä E., Cantell K. No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Jun;82(3):305–310. doi: 10.1111/j.1699-0463.1974.tb02331.x. [DOI] [PubMed] [Google Scholar]
  145. Morser J., Kabayo J. P., Hutchinson D. W. Differences in sialic acid content of human interferons. J Gen Virol. 1978 Oct;41(1):175–178. doi: 10.1099/0022-1317-41-1-175. [DOI] [PubMed] [Google Scholar]
  146. Morser J., Meager A., Colman A. Enhancement of interferon mRNA levels in butyric acid-treated Namalwa cells. FEBS Lett. 1980 Apr 7;112(2):203–206. doi: 10.1016/0014-5793(80)80180-3. [DOI] [PubMed] [Google Scholar]
  147. Muthukrishnan S., Shatkin A. J. Reovirus genome RNA segments: resistance to S-1 nuclease. Virology. 1975 Mar;64(1):96–105. doi: 10.1016/0042-6822(75)90082-3. [DOI] [PubMed] [Google Scholar]
  148. Nagata S., Taira H., Hall A., Johnsrud L., Streuli M., Ecsödi J., Boll W., Cantell K., Weissmann C. Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature. 1980 Mar 27;284(5754):316–320. doi: 10.1038/284316a0. [DOI] [PubMed] [Google Scholar]
  149. Nilsen T. W., Baglioni C. Mechanism for discrimination between viral and host mRNA in interferon-treated cells. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2600–2604. doi: 10.1073/pnas.76.6.2600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Nilsen T. W., Wood D. L., Baglioni C. Virus-specific effects of interferon in embryonal carcinoma cells. Nature. 1980 Jul 10;286(5769):178–180. doi: 10.1038/286178a0. [DOI] [PubMed] [Google Scholar]
  151. Nordlund J. J., Wolff S. M., Levy H. B. Inhibition of biologic activity of poly I: poly C by human plasma. Proc Soc Exp Biol Med. 1970 Feb;133(2):439–444. doi: 10.3181/00379727-133-34492. [DOI] [PubMed] [Google Scholar]
  152. Novokhatsky A. S., Ershov F. I., Timkovsky A. L., Bresler S. E., Kogan E. M., Tikhomirova-Sidorova N. S. Double-stranded complex of polyguanylic and polycytidylic acids and its antiviral activity in tissue culture. Acta Virol. 1975 Apr;19(2):121–129. [PubMed] [Google Scholar]
  153. O'Malley J. A., Ho Y. K., Chakrabarti P., DiBerardino L., Chandra P., Orinda D. A., Byrd D. M., Bardos T. J., Carter W. A. Antiviral activity of partially thiolated polynucleotides. Mol Pharmacol. 1975 Jan;11(1):61–69. [PubMed] [Google Scholar]
  154. O'Malley J. A., Leong S. S., Horoszewicz J. S., Carter W. A., Alderfer J. L., Ts'o P. O. Polyinosinic acid-polycytidylic acid and its mismatched analogues: differential effects on human cell function. Mol Pharmacol. 1979 Jan;15(1):165–173. [PubMed] [Google Scholar]
  155. OHNO S., NOZIMA T. INHIBITORY EFFECT OF INTERFERON ON THE INDUCTION OF THYMIDINE KINASE IN VACCINIA VIRUS-INFECTED CHICK EMBRYO FIBROBLASTS. Acta Virol. 1964 Sep;8:479–479. [PubMed] [Google Scholar]
  156. Ohtsuki K., Baron S. An interferon-induced, ribosome-associated protein kinase which reduces the activity of initiation factor. J Biochem. 1979 Jun;85(6):1495–1502. doi: 10.1093/oxfordjournals.jbchem.a132478. [DOI] [PubMed] [Google Scholar]
  157. Ohtsuki K., Dianzani F., Baron S. Decreased initiation factor activity in mouse L cells treated with interferon. Nature. 1977 Oct 6;269(5628):536–538. doi: 10.1038/269536a0. [DOI] [PubMed] [Google Scholar]
  158. Pestka S., McInnes J., Havell E. A., Vilcek J. Cell-free synthesis of human interferon. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3898–3901. doi: 10.1073/pnas.72.10.3898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Pitha J., Pitha P. M. Antiviral resistance by the polyinosinic acid-poly (1-vinylcytosine) complex. Science. 1971 Jun 11;172(3988):1146–1148. doi: 10.1126/science.172.3988.1146. [DOI] [PubMed] [Google Scholar]
  160. Ratner L., Sen G. C., Brown G. E., Lebleu B., Kawakita M., Cabrer B., Slattery E., Lengyel P. Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity. Eur J Biochem. 1977 Oct 3;79(2):565–577. doi: 10.1111/j.1432-1033.1977.tb11841.x. [DOI] [PubMed] [Google Scholar]
  161. Ratner L., Wiegand R. C., Farrell P. J., Sen G. C., Cabrer B., Lengyel P. Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation. Biochem Biophys Res Commun. 1978 Apr 14;81(3):947–954. doi: 10.1016/0006-291x(78)91443-2. [DOI] [PubMed] [Google Scholar]
  162. Reuss K., Scheit K. H., Saiko O. Induction of interferon by polyribonucleotides containing thiopyrimidines. Nucleic Acids Res. 1976 Oct;3(10):2861–2875. doi: 10.1093/nar/3.10.2861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Reynolds F. H., Jr, Premkumar E., Pitha P. M. Interferon activity produced by translation of human interferon messenger RNA in cell-free ribosomal systems and in Xenopus oöcytes. Proc Natl Acad Sci U S A. 1975 Dec;72(12):4881–4885. doi: 10.1073/pnas.72.12.4881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Riggs M. G., Whittaker R. G., Neumann J. R., Ingram V. M. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Nature. 1977 Aug 4;268(5619):462–464. doi: 10.1038/268462a0. [DOI] [PubMed] [Google Scholar]
  165. Roberts W. K., Clemens M. J., Kerr I. M. Interferon-induced inhibition of protein synthesis in L-cell extracts: an ATP-dependent step in the activation of an inhibitor by double-stranded RNA. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3136–3140. doi: 10.1073/pnas.73.9.3136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Roberts W. K., Hovanessian A., Brown R. E., Clemens M. J., Kerr I. M. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature. 1976 Dec 2;264(5585):477–480. doi: 10.1038/264477a0. [DOI] [PubMed] [Google Scholar]
  167. Robinson R. A., DeVita V. T., Levy H. B., Baron S., Hubbard S. P., Levine A. S. A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Inst. 1976 Sep;57(3):599–602. doi: 10.1093/jnci/57.3.599. [DOI] [PubMed] [Google Scholar]
  168. Rose J. K., Trachsel H., Leong K., Baltimore D. Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A. 1978 Jun;75(6):2732–2736. doi: 10.1073/pnas.75.6.2732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Rubinstein M., Rubinstein S., Familletti P. C., Miller R. S., Waldman A. A., Pestka S. Human leukocyte interferon: production, purification to homogeneity, and initial characterization. Proc Natl Acad Sci U S A. 1979 Feb;76(2):640–644. doi: 10.1073/pnas.76.2.640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Samuel C. E. Mechanism of interferon action. Kinetics of interferon action in mouse L929 cells: phosphorylation of protein synthesis initiation factor elF-2 and ribosome-associated protein P1. Virology. 1979 Feb;93(1):281–285. doi: 10.1016/0042-6822(79)90300-3. [DOI] [PubMed] [Google Scholar]
  171. Samuel C. E. Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci U S A. 1979 Feb;76(2):600–604. doi: 10.1073/pnas.76.2.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  172. Schmidt A., Chernajovsky Y., Shulman L., Federman P., Berissi H., Revel M. An interferon-induced phosphodiesterase degrading (2'-5') oligoisoadenylate and the C-C-A terminus of tRNA. Proc Natl Acad Sci U S A. 1979 Oct;76(10):4788–4792. doi: 10.1073/pnas.76.10.4788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Schmidt A., Zilberstein A., Shulman L., Federman P., Berissi H., Revel M. Interferon action: isolation of nuclease F, a translation inhibitor activated by interferon-induced (2'-5') oligo-isoadenylate. FEBS Lett. 1978 Nov 15;95(2):257–264. doi: 10.1016/0014-5793(78)81006-0. [DOI] [PubMed] [Google Scholar]
  174. Schur P. H., Monroe M. Antibodies to ribonucleic acid in systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1108–1112. doi: 10.1073/pnas.63.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Sehgal P. B., Gupta S. L. Regulation of the stability of poly(I)xpoly(C)-induced human fibroblast interferon mRNA: selective inactivation of interferon mRNA and lack of involvement of 2',5'-oligo(A) synthetase activation during the shutoff of interferon production. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3489–3493. doi: 10.1073/pnas.77.6.3489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Sehgal P. B., Sagar A. D. Heterogeneity of poly(I) x poly(C)-induced human fibroblast interferon mRNA species. Nature. 1980 Nov 6;288(5786):95–97. doi: 10.1038/288095a0. [DOI] [PubMed] [Google Scholar]
  177. Sehgal P. B., Tamm I. Two mechanisms contribute to the superinduction of poly(I).poly(C)-induced human fibroblast interferon production. Virology. 1979 Jan 15;92(1):240–244. doi: 10.1016/0042-6822(79)90230-7. [DOI] [PubMed] [Google Scholar]
  178. Semancik J. S., Vidaver A. K., Van Etten J. L. Characterization of segmented double-helical RNA from bacteriophage phi6. J Mol Biol. 1973 Aug 25;78(4):617–625. doi: 10.1016/0022-2836(73)90283-0. [DOI] [PubMed] [Google Scholar]
  179. Sen G. C., Gupta S. L., Brown G. E., Lebleu B., Rebello M. A., Lengyel P. Interferon treatment of Ehrlich ascites tumor cells: effects on exogenous mRNA translation and tRNA inactivation in the cell extract. J Virol. 1975 Jan;17(1):191–203. doi: 10.1128/jvi.17.1.191-203.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Sen G. C., Lebleu B., Brown G. E., Kawakita M., Slattery E., Lengyel P. Interferon, double-stranded RNA and mRNA degradation. Nature. 1976 Nov 25;264(5584):370–373. doi: 10.1038/264370a0. [DOI] [PubMed] [Google Scholar]
  181. Sen G. C., Lebleu B., Brown G. E., Rebello M. A., Furuichi Y., Morgan M., Shatkin A. J., Lengyel P. Inhibition of reovirus messenger RNA methylation in extracts of interferon-treated Ehrlich ascites tumor cells. Biochem Biophys Res Commun. 1975 Jul 8;65(1):427–434. doi: 10.1016/s0006-291x(75)80111-2. [DOI] [PubMed] [Google Scholar]
  182. Sen G. C., Shaila S., Lebleu B., Brown G. E., Desrosiers R. C., Lengyel P. Impairment of reovirus mRNA methylation in extracts of interferon-treated Ehrilich ascites tumor cells: further characteristics of the phenomenon. J Virol. 1977 Jan;21(1):69–83. doi: 10.1128/jvi.21.1.69-83.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Sen G. C., Taira H., Lengyel P. Interferon, double-stranded RNA, and protein phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system partially purified from interferon treated Ehrlich ascites tumor cells. J Biol Chem. 1978 Sep 10;253(17):5915–5921. [PubMed] [Google Scholar]
  184. Sergiescu D., Cerutti I., Efthymiou E., Kahan A., Chany C. Adverse effects of interferon treatment on the life span of NZB mice. Biomedicine. 1979 Apr;31(2):48–51. [PubMed] [Google Scholar]
  185. Shimizu N., Sokawa Y. 2',5'-Oligoadenylate synthetase activity in lymphocytes from normal mouse. J Biol Chem. 1979 Dec 10;254(23):12034–12037. [PubMed] [Google Scholar]
  186. Slattery E., Ghosh N., Samanta H., Lengyel P. Interferon, double-stranded RNA, and RNA degradation: activation of an endonuclease by (2'-5')An. Proc Natl Acad Sci U S A. 1979 Oct;76(10):4778–4782. doi: 10.1073/pnas.76.10.4778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Smorodintsev A. A. Studies on the use of interferon inducers in man and animals. Acta Biol Med Ger. 1979;38(5-6):867–871. [PubMed] [Google Scholar]
  188. Sonenberg N., Rupprecht K. M., Hecht S. M., Shatkin A. J. Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4345–4349. doi: 10.1073/pnas.76.9.4345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Sonnenfeld G., Mandel A. D., Merigan T. C. The immunosuppressive effect of type II mouse interferon preparations on antibody production. Cell Immunol. 1977 Dec;34(2):193–206. doi: 10.1016/0008-8749(77)90243-x. [DOI] [PubMed] [Google Scholar]
  190. Stark G. R., Dower W. J., Schimke R. T., Brown R. E., Kerr I. M. 2-5A synthetase: assay, distribution and variation with growth or hormone status. Nature. 1979 Mar 29;278(5703):471–473. doi: 10.1038/278471a0. [DOI] [PubMed] [Google Scholar]
  191. Stebbing N., Dawson K. M. The formation of complexes between polynucleotides, carboxymethylcellulose and polylysine which are anti-viral in mice without inducing interferon. Mol Pharmacol. 1979 Jul;16(1):313–323. [PubMed] [Google Scholar]
  192. Steinberg A. D., Baron S., Talal N. The pathogenesis of autoimmunity in New Zealand mice, I. Induction of antinucleic acid antibodies by polyinosinic-polycytidylic acid. Proc Natl Acad Sci U S A. 1969 Aug;63(4):1102–1107. doi: 10.1073/pnas.63.4.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Stern R. A nuclease from animal serum which hydrolyzes double-stranded RNA. Biochem Biophys Res Commun. 1970 Nov 9;41(3):608–614. doi: 10.1016/0006-291x(70)90056-2. [DOI] [PubMed] [Google Scholar]
  194. Stewart W. E., 2nd, De Clercq E., Billiau A., Desmyter J., De Somer P. Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid. Proc Natl Acad Sci U S A. 1972 Jul;69(7):1851–1854. doi: 10.1073/pnas.69.7.1851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Stewart W. E., 2nd, De Clercq E., De Somer P. Cellular alteration by interferon: a virus-free system for assaying interferon. J Virol. 1972 Nov;10(5):896–901. doi: 10.1128/jvi.10.5.896-901.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Stewart W. E., 2nd, De Clercq E., De Somer P. Specificity of interferon-induced enhancement of toxicity for double-stranded ribonucleic acids. J Gen Virol. 1973 Mar;18(3):237–246. doi: 10.1099/0022-1317-18-3-237. [DOI] [PubMed] [Google Scholar]
  197. Taira H., Broeze R. J., Jayaram B. M., Lengyel P., Hunkapiller M. W., Hood L. E. Mouse interferons: amino terminal amino acid sequences of various species. Science. 1980 Feb 1;207(4430):528–530. doi: 10.1126/science.7352261. [DOI] [PubMed] [Google Scholar]
  198. Tan Y. H., Barakat F., Berthold W., Smith-Johannsen H., Tan C. The isolation and amino acid/sugar composition of human fibroblastoid interferon. J Biol Chem. 1979 Aug 25;254(16):8067–8073. [PubMed] [Google Scholar]
  199. Taniguchi T., Mantei N., Schwarzstein M., Nagata S., Muramatsu M., Weissmann C. Human leukocyte and fibroblast interferons are structurally related. Nature. 1980 Jun 19;285(5766):547–549. doi: 10.1038/285547a0. [DOI] [PubMed] [Google Scholar]
  200. Taniguchi T., Ohno S., Fujii-Kuriyama Y., Muramatsu M. The nucleotide sequence of human fibroblast interferon cDNA. Gene. 1980 Jun;10(1):11–15. doi: 10.1016/0378-1119(80)90138-9. [DOI] [PubMed] [Google Scholar]
  201. Thang M. N., Thang D. C., De Maeyer E., Montagnier L. Biosynthesis of mouse interferon by translation of its messenger RNA in a cell-free system. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3975–3977. doi: 10.1073/pnas.72.10.3975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Torrence P. F., De Clercq E., Waters J. A., Witkop B. A potent interferon inducer derived from poly (7-deazainosinic acid). Biochemistry. 1974 Oct 8;13(21):4400–4408. doi: 10.1021/bi00718a025. [DOI] [PubMed] [Google Scholar]
  203. Torrence P. F., Friedman R. M. Are double-stranded RNA-directed inhibition of protein synthesis in interferon-treated cells and interferon induction related phenomena? J Biol Chem. 1979 Feb 25;254(4):1259–1267. [PubMed] [Google Scholar]
  204. Trachsel H., Sonenberg N., Shatkin A. J., Rose J. K., Leong K., Bergmann J. E., Gordon J., Baltimore D. Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells. Proc Natl Acad Sci U S A. 1980 Feb;77(2):770–774. doi: 10.1073/pnas.77.2.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Trachsel H., Staehelin T. Binding and release of eukaryotic initiation factor eIF-2 and GTP during protein synthesis initiation. Proc Natl Acad Sci U S A. 1978 Jan;75(1):204–208. doi: 10.1073/pnas.75.1.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Tytell A. A., Lampson G. P., Field A. K., Nemes M. M., Hilleman M. R. Influence of size of individual homopolynucleotides on the physical and biological properties of complexed rIn:rCn (poly I:C). Proc Soc Exp Biol Med. 1970 Dec;135(3):917–921. doi: 10.3181/00379727-135-35170. [DOI] [PubMed] [Google Scholar]
  208. Van Etten J. L., Vidaver A. K., Koski R. K., Burnett J. P. Base composition and hybridization studies of the three double-stranded RNA segments of bacteriophage phi 6. J Virol. 1974 Jun;13(6):1254–1262. doi: 10.1128/jvi.13.6.1254-1262.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  209. Vaquero C. M., Clemens M. J. Inhibition of protein synthesis and activation of nuclease in rabbit reticulocyte lysates by the unusual oligonucleotide pppA2'p5'A2'p5'A. Eur J Biochem. 1979 Jul;98(1):245–252. doi: 10.1111/j.1432-1033.1979.tb13182.x. [DOI] [PubMed] [Google Scholar]
  210. Vengris V. E., Stollar B. D., Pitha P. M. Interferon externalization by producing cell before induction of antiviral state. Virology. 1975 Jun;65(2):410–417. doi: 10.1016/0042-6822(75)90046-x. [DOI] [PubMed] [Google Scholar]
  211. Vidaver A. K., Koski R. K., Van Etten J. L. Bacteriophage phi6: a Lipid-Containing Virus of Pseudomonas phaseolicola. J Virol. 1973 May;11(5):799–805. doi: 10.1128/jvi.11.5.799-805.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Volckaert-Vervliet G., De Clercq E., Billiau A. Interaction of polyriboinosinic acid, polyribocytidylic acid with human lymphoblastoid cells. Biochem Biophys Res Commun. 1980 Feb 12;92(3):833–838. doi: 10.1016/0006-291x(80)90778-0. [DOI] [PubMed] [Google Scholar]
  213. Wellauer P. K., Dawid I. B. Secondary structure maps of RNA: processing of HeLa ribosomal RNA. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2827–2831. doi: 10.1073/pnas.70.10.2827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  214. West D. K., Baglioni C. Induction of interferon in HeLa cells of a protein kinase activated by double-stranded RNA. Eur J Biochem. 1979 Nov;101(2):461–468. doi: 10.1111/j.1432-1033.1979.tb19740.x. [DOI] [PubMed] [Google Scholar]
  215. Wheelock E. F. Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin. Science. 1965 Jul 16;149(3681):310–311. doi: 10.1126/science.149.3681.310. [DOI] [PubMed] [Google Scholar]
  216. Wiebe M. E., Joklik T. W. The mechanism of inhibition of reovirus replication by interferon. Virology. 1975 Jul;66(1):229–240. doi: 10.1016/0042-6822(75)90193-2. [DOI] [PubMed] [Google Scholar]
  217. Williams B. R., Gilbert C. S., Kerr I. M. The respective roles of the protein kinase and pppA2' p5' A2' p5 A-activated endonuclease in the inhibition of protein synthesis by double stranded RNA in rabbit reticulocyte lysates. Nucleic Acids Res. 1979 Apr;6(4):1335–1350. doi: 10.1093/nar/6.4.1335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  218. Williams B. R., Golgher R. R., Brown R. E., Gilbert C. S., Kerr I. M. Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Nature. 1979 Dec 6;282(5739):582–586. doi: 10.1038/282582a0. [DOI] [PubMed] [Google Scholar]
  219. Williams B. R., Golgher R. R., Kerr I. M. Activation of a nuclease by pppA2'p5'A2'p5'A in intact cells. FEBS Lett. 1979 Sep 1;105(1):47–52. doi: 10.1016/0014-5793(79)80885-6. [DOI] [PubMed] [Google Scholar]
  220. Williams B. R., Kerr I. M., Gilbert C. S., White C. N., Ball L. A. Synthesis and breakdown of pppA2'p5'A2'p5'A and transient inhibiton of protein synthesis in extracts from interferon-treated and control cells. Eur J Biochem. 1978 Dec;92(2):455–462. doi: 10.1111/j.1432-1033.1978.tb12767.x. [DOI] [PubMed] [Google Scholar]
  221. Williams B. R., Kerr I. M. Inhibition of protein synthesis by 2'-5' linked adenine oligonucleotides in intact cells. Nature. 1978 Nov 2;276(5683):88–90. doi: 10.1038/276088a0. [DOI] [PubMed] [Google Scholar]
  222. Wood J. N., Hovanessian A. G. Interferon enhances 2-5A synthetase in embryonal carcinoma cells. Nature. 1979 Nov 1;282(5734):74–76. doi: 10.1038/282074a0. [DOI] [PubMed] [Google Scholar]
  223. Wreschner D. H., McCauley J. W., Skehel J. J., Kerr I. M. Interferon action--sequence specificity of the ppp(A2'p)nA-dependent ribonuclease. Nature. 1981 Jan 29;289(5796):414–417. doi: 10.1038/289414a0. [DOI] [PubMed] [Google Scholar]
  224. Yakobson E., Prives C., Hartman J. R., Winocour E., Revel M. Inhibition of viral protein synthesis in monkey cells treated with interferon late in simian virus 40 lytic cycle. Cell. 1977 Sep;12(1):73–81. doi: 10.1016/0092-8674(77)90186-6. [DOI] [PubMed] [Google Scholar]
  225. Yamamoto K., Yamaguchi N., Oda K. Mechanism of interferon-induced inhibition of early simian virus 40(SV40) functions. Virology. 1975 Nov;68(1):58–70. doi: 10.1016/0042-6822(75)90147-6. [DOI] [PubMed] [Google Scholar]
  226. Yau P. M., Godefroy-Colburn T., Birge C. H., Ramabhadran T. V., Thach R. E. Specificity of interferon action in protein synthesis. J Virol. 1978 Sep;27(3):648–658. doi: 10.1128/jvi.27.3.648-658.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Zilberstein A., Federman P., Shulman L., Revel M. Specific phosphorylation in vitro of a protein associated with ribosomes of interferon-treated mouse L cells. FEBS Lett. 1976 Sep 15;68(1):119–124. doi: 10.1016/0014-5793(76)80418-8. [DOI] [PubMed] [Google Scholar]
  228. Zilberstein A., Kimchi A., Schmidt A., Revel M. Isolation of two interferon-induced translational inhibitors: a protein kinase and an oligo-isoadenylate synthetase. Proc Natl Acad Sci U S A. 1978 Oct;75(10):4734–4738. doi: 10.1073/pnas.75.10.4734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Zoon K. C., Smith M. E., Bridgen P. J., Anfinsen C. B., Hunkapiller M. W., Hood L. E. Amino terminal sequence of the major component of human lymphoblastoid interferon. Science. 1980 Feb 1;207(4430):527–528. doi: 10.1126/science.7352260. [DOI] [PubMed] [Google Scholar]
  230. Zoon K. C., Smith M. E., Bridgen P. J., zur Nedden D., Anfinsen C. B. Purification and partial characterization of human lymphoblast interferon. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5601–5605. doi: 10.1073/pnas.76.11.5601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  231. de Clercq E. Degradation of poly(inosinic acid) - poly(cytidylic acid) [(I)n - (C)n] by human plasma. Eur J Biochem. 1979 Jan 2;93(1):165–172. doi: 10.1111/j.1432-1033.1979.tb12807.x. [DOI] [PubMed] [Google Scholar]
  232. de Clercq E., Torrence P. F., Stollar B. D., Hobbs J., Fukui T., Kakiuchi N., Ikehara M. Interferon induction by a 2'-modified double-helical RNA, poly(2'-azido-2'-deoxyinosinic acid) . polycytidylic acid. Eur J Biochem. 1978 Aug 1;88(2):341–349. doi: 10.1111/j.1432-1033.1978.tb12455.x. [DOI] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES